PSMD14 and pachyonychia congenita: Kaplan–Meier survival analysis revealed significantly shorter overall survival in patients with elevated PSMD14 expression (Figure S3G, Supporting Information), emphasizing the relationship between PSMD14 expression and PC patient prognosis.